Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: OxyContin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
OxyContin 10mg modified-release tablets
0407020ADBCAAAF
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 4,817 |
|
OxyContin 20mg modified-release tablets
0407020ADBCABAG
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 3,029 |
|
OxyContin 5mg modified-release tablets
0407020ADBCAEAK
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 1,674 |
|
OxyContin 40mg modified-release tablets
0407020ADBCACAH
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 1,206 |
|
OxyContin 30mg modified-release tablets
0407020ADBCAHAR
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 968 |
|
OxyContin 80mg modified-release tablets
0407020ADBCADAI
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 597 |
|
OxyContin 15mg modified-release tablets
0407020ADBCAIAS
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 520 |
|
OxyContin 60mg modified-release tablets
0407020ADBCAGAQ
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 392 |
|
OxyContin 120mg modified-release tablets
0407020ADBCAFAP
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 50 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.